vs
ISABELLA BANK CORP（ISBA）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
ISABELLA BANK CORP的季度营收约是STANDARD BIOTOOLS INC.的1.1倍（$21.2M vs $19.6M），ISABELLA BANK CORP净利率更高（22.2% vs -177.4%，领先199.6%），ISABELLA BANK CORP同比增速更快（14.3% vs -11.5%），ISABELLA BANK CORP自由现金流更多（$23.3M vs $-23.1M），过去两年ISABELLA BANK CORP的营收复合增速更高（12.6% vs -12.2%）
菲律宾群岛银行是菲律宾的全能型银行，同时也是菲律宾乃至整个东南亚历史最悠久的银行。按资产规模计算，它是菲律宾第四大银行；按市值计算则位列第二，是菲律宾盈利能力最强的银行之一。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
ISBA vs LAB — 直观对比
营收规模更大
ISBA
是对方的1.1倍
$19.6M
营收增速更快
ISBA
高出25.7%
-11.5%
净利率更高
ISBA
高出199.6%
-177.4%
自由现金流更多
ISBA
多$46.4M
$-23.1M
两年增速更快
ISBA
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $21.2M | $19.6M |
| 净利润 | $4.7M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 32.2% | -168.5% |
| 净利率 | 22.2% | -177.4% |
| 营收同比 | 14.3% | -11.5% |
| 净利润同比 | 17.4% | -28.8% |
| 每股收益（稀释后） | $0.64 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ISBALAB
| Q4 25 | $21.2M | — | ||
| Q3 25 | $20.5M | $19.6M | ||
| Q2 25 | $18.8M | $21.8M | ||
| Q1 25 | $18.1M | $40.8M | ||
| Q4 24 | $18.5M | — | ||
| Q3 24 | $18.0M | $22.1M | ||
| Q2 24 | $17.2M | $22.5M | ||
| Q1 24 | $16.7M | $45.5M |
净利润ISBALAB
| Q4 25 | $4.7M | — | ||
| Q3 25 | $5.2M | $-34.7M | ||
| Q2 25 | $5.0M | $-33.5M | ||
| Q1 25 | $3.9M | $-26.0M | ||
| Q4 24 | $4.0M | — | ||
| Q3 24 | $3.3M | $-26.9M | ||
| Q2 24 | $3.5M | $-45.7M | ||
| Q1 24 | $3.1M | $-32.2M |
毛利率ISBALAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率ISBALAB
| Q4 25 | 32.2% | — | ||
| Q3 25 | 30.7% | -168.5% | ||
| Q2 25 | 32.8% | -118.1% | ||
| Q1 25 | 26.9% | -80.8% | ||
| Q4 24 | 26.0% | — | ||
| Q3 24 | 21.3% | -120.9% | ||
| Q2 24 | 23.9% | -134.5% | ||
| Q1 24 | 21.8% | -132.2% |
净利率ISBALAB
| Q4 25 | 22.2% | — | ||
| Q3 25 | 25.6% | -177.4% | ||
| Q2 25 | 26.7% | -153.7% | ||
| Q1 25 | 21.9% | -63.8% | ||
| Q4 24 | 21.6% | — | ||
| Q3 24 | 18.2% | -122.0% | ||
| Q2 24 | 20.3% | -203.3% | ||
| Q1 24 | 18.7% | -70.6% |
每股收益（稀释后）ISBALAB
| Q4 25 | $0.64 | — | ||
| Q3 25 | $0.71 | $-0.09 | ||
| Q2 25 | $0.68 | $-0.09 | ||
| Q1 25 | $0.53 | $-0.07 | ||
| Q4 24 | $0.54 | — | ||
| Q3 24 | $0.44 | $-0.07 | ||
| Q2 24 | $0.46 | $-0.12 | ||
| Q1 24 | $0.42 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $26.0M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $231.4M | $399.7M |
| 总资产 | $2.2B | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ISBALAB
| Q4 25 | $26.0M | — | ||
| Q3 25 | $161.3M | $129.4M | ||
| Q2 25 | $108.6M | $158.6M | ||
| Q1 25 | $69.2M | $150.9M | ||
| Q4 24 | $24.5M | — | ||
| Q3 24 | $27.4M | $210.6M | ||
| Q2 24 | $23.6M | $269.8M | ||
| Q1 24 | $25.2M | $287.1M |
总债务ISBALAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益ISBALAB
| Q4 25 | $231.4M | — | ||
| Q3 25 | $227.4M | $399.7M | ||
| Q2 25 | $220.5M | $424.5M | ||
| Q1 25 | $215.6M | $454.6M | ||
| Q4 24 | $210.3M | — | ||
| Q3 24 | $213.0M | $489.3M | ||
| Q2 24 | $202.2M | $510.3M | ||
| Q1 24 | $200.7M | $577.3M |
总资产ISBALAB
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.3B | $539.6M | ||
| Q2 25 | $2.2B | $557.0M | ||
| Q1 25 | $2.1B | $579.6M | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | $681.5M | ||
| Q2 24 | $2.1B | $708.7M | ||
| Q1 24 | $2.1B | $777.7M |
负债/权益比ISBALAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.8M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $23.3M | $-23.1M |
| 自由现金流率自由现金流/营收 | 110.2% | -118.1% |
| 资本支出强度资本支出/营收 | 16.4% | 4.5% |
| 现金转化率经营现金流/净利润 | 5.72× | — |
| 过去12个月自由现金流最近4个季度 | $36.0M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流ISBALAB
| Q4 25 | $26.8M | — | ||
| Q3 25 | $2.7M | $-22.2M | ||
| Q2 25 | $7.8M | $-20.7M | ||
| Q1 25 | $4.7M | $-30.3M | ||
| Q4 24 | $19.6M | — | ||
| Q3 24 | $3.6M | $-27.9M | ||
| Q2 24 | $5.5M | $-39.0M | ||
| Q1 24 | $3.4M | $-62.5M |
自由现金流ISBALAB
| Q4 25 | $23.3M | — | ||
| Q3 25 | $1.7M | $-23.1M | ||
| Q2 25 | $7.2M | $-22.6M | ||
| Q1 25 | $3.7M | $-35.3M | ||
| Q4 24 | $17.5M | — | ||
| Q3 24 | $3.2M | $-30.1M | ||
| Q2 24 | $5.1M | $-41.0M | ||
| Q1 24 | $2.6M | $-63.3M |
自由现金流率ISBALAB
| Q4 25 | 110.2% | — | ||
| Q3 25 | 8.5% | -118.1% | ||
| Q2 25 | 38.5% | -103.6% | ||
| Q1 25 | 20.6% | -86.6% | ||
| Q4 24 | 94.6% | — | ||
| Q3 24 | 17.7% | -136.4% | ||
| Q2 24 | 29.8% | -182.2% | ||
| Q1 24 | 15.7% | -138.9% |
资本支出强度ISBALAB
| Q4 25 | 16.4% | — | ||
| Q3 25 | 5.0% | 4.5% | ||
| Q2 25 | 3.2% | 8.7% | ||
| Q1 25 | 5.5% | 12.4% | ||
| Q4 24 | 11.4% | — | ||
| Q3 24 | 2.0% | 10.2% | ||
| Q2 24 | 2.4% | 8.6% | ||
| Q1 24 | 4.9% | 1.7% |
现金转化率ISBALAB
| Q4 25 | 5.72× | — | ||
| Q3 25 | 0.52× | — | ||
| Q2 25 | 1.56× | — | ||
| Q1 25 | 1.19× | — | ||
| Q4 24 | 4.91× | — | ||
| Q3 24 | 1.08× | — | ||
| Q2 24 | 1.59× | — | ||
| Q1 24 | 1.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ISBA
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
